|
 |
New diagnostic tests that provide information to physicians and patients that can be acted upon
 |
With the information from emerging diagnostic tests, physicians may be able to recommend earlier treatments or lifestyle changes, and choose between alternative therapies. Early diagnosis through Targeted Medicine may mean patients can take actions to improve their health and quality of life, while avoiding or delaying chronic disease development. |
New therapies to intervene in disease development
|
Targeted Medicine enables our scientists to discover new genetically validated targets and potential treatments for serious, life-threatening conditions that have a genetic component. Development efforts at Celera Genomics seek to yield drugs that are directed against specific sub-classes of complex diseases. |
Therapies intended to address the needs of specific patient populations
|
Patients want to feel confident they will benefit from a drug, while minimizing their risk of negative side effects. Targeted Medicine may improve drug efficacy while avoiding side effects by applying a better understanding of genetic associations to disease, both in the development and administration of drugs. Within a stratified patient population, an experimental drug may exhibit more consistent efficacy and fewer adverse reactions and require a smaller clinical trial population, thus eliminating some common barriers to successful clinical trials. Targeted Medicine is intended to focus the drug development process to bring safe, effective treatments to market sooner for the patients who need them. |
Improving the odds that a potential drug candidate will pass clinical testing and approval processes
|
Industry averages show that it takes 10 years and $800 million to bring a new drug from the laboratory to patients, and, even then, only one in ten potential drugs tested in humans successfully reach the marketplace. Meanwhile, patients have their hopes raised for a new treatment, only to have them dashed when a drug candidate fails to be proven safe or effective in clinical studies.
|
|
|
|
|
|
The well-characterized markers and targets from Targeted Medicine are more likely to lead to effective diagnostics and drugs.
|
|
|
|
 |
|
